One of the biggest drug highlights at the 2015 ADA Scientific Sessions was a compelling presentation by diaTribe scientific Advisory Board member Dr. John Buse on brand...
Diabetes Drug News
Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.
Metformin Insulin SGLT-2 GLP-1 DPP-4 Combo drugs Sulfonylureas TZDs
51 readers recommended
First-ever SGLT-2/DPP-4 inhibitor drug, will this combination cut costs for patients?
38 readers recommended
Over seven million Americans have diabetic retinopathy – how Eylea provides another treatment for this serious complication.
21 readers recommended
How will a new drug fare in a 4,000-patient, four-year study?
25 readers recommended
Another diabetes drug that helps people lose weight?
31 readers recommended
Twitter summary: JAMA study shows that metformin is safest first-line therapy for type 2 diabetes – future GRADE study to show best second-line therapy The journal JAMA...
34 readers recommended
Current trial results show that obese patients using Contrave are about 41% less likely to experience any major heart event (e.g. heart attack, strokes, or heart-related...
41 readers recommended
After the rapid-acting inhaled insulin Afrezza launched this February, we have been very eager to learn more about how this new product impacts patients’ day-to-day...
37 readers recommended
ClinicalTrials.gov Identifier: NCT00920582 This study is currently recruiting patients recently diagnosed with type 1 diabetes to investigate the efficacy of teplizumab...
25 readers recommended
Submitted to the FDA and could be approved this year.
25 readers recommended
$300 million and counting – how much have we learned from the heart safety trials of Onglyza and Nesina?
25 readers recommended
Zosano Pharma is making early progress with an innovative patch-based glucagon delivery system for severe hypoglycemia, recently announcing that it has completed...
33 readers recommended
When might this product reach the market?
35 readers recommended
Smartphone user interface with no screen or buttons on the pump! Launch: 2018?
24 readers recommended
And “potentially transformative” advances coming for type 1 diabetes.
39 readers recommended
New trial testing the inhaled, ultra-rapid insulin in 4-17 year olds.
34 readers recommended
Flat insulin allows for flexible dosing with lower likelihood of hypoglycemia. How is it priced vs. Levemir?
20 readers recommended
Praluent now approved for two specific patient populations. How this drug has the future potential to make a big impact on people with diabetes.
46 readers recommended
Gamechanging Xultophy (Tresiba + Victoza) also now submitted to the FDA.
34 readers recommended
Launch before the second half of 2016. What savings program will be offered?